Document:

Exhibit 4.1

 

Exhibit
4.1 

 

NEITHER
THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE
OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR ANY OTHER SECURITIES LAWS (THE
“ACTS”). NEITHER THIS WARRANT NOR THE SHARES OF COMMON
STOCK PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR
HYPOTHECATED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THIS WARRANT OR COMMON STOCK PURCHASABLE HEREUNDER,
AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.

 

YOUNGEVITY
INTERNATIONAL, INC.

WARRANT
AGREEMENT

 

VOID
AFTER 5:00 P.M. NEW YORK TIME, _________________, 20__

 

Issue
Date:

 

1. Basic Terms. This Warrant
Agreement (the “Warrant”) certifies that, for value
received, the registered holder specified below or its registered
assigns (“Holder”) is the owner of a warrant of
Youngevity International, Inc., a Delaware corporation having its
principal place of business at 2400 Boswell Road, Chula Vista,
California 91914 (the “Corporation”), subject to
adjustments as provided herein, to purchase _______________________
(_________) shares of the Common Stock, $0.001 par value, of the
Corporation (the “Common Stock”) from the Corporation
at the price per share shown below (the “Exercise
Price”).

	

 

Holder:

 

	
 

	

Exercise Price per
share:

	

$4.75

 

Except
as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock
purchasable hereunder shall be to the Exercise Price and number of
shares after any adjustments are made thereto pursuant to this
Warrant.

 

2. 
Corporation’s
Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the
exercise of this Warrant shall at delivery be fully paid and
non-assessable and free from taxes, liens, encumbrances and charges
with respect to their purchase. The Corporation shall take any
necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current
Exercise Price per share of Common Stock issuable pursuant to this
Warrant. The Corporation shall at all times reserve and hold
available sufficient shares of Common Stock to satisfy all
conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this
Warrant.

 

3. 
Method of Exercise; Fractional
Shares. This Warrant is exercisable at the option of the
Holder at any time by surrendering this Warrant, on any business
day during the period (the “Exercise Period”) beginning
the business day after the issue date of this Warrant specified
above and ending at 5:00 p.m. (New York time) two (2) years after
the issue date. To exercise this Warrant, the Holder shall
surrender this Warrant at the principal office of the Corporation
or that of the duly authorized and acting transfer agent for its
Common Stock, together with the executed exercise form
(substantially in the form attached hereto) and payment in cash or
by wire transfer of immediately available funds of an amount equal
to the Exercise Price multiplied by the number of shares of the
Common Stock being purchased under this Warrant. The principal
office of the Corporation is located at the address specified in
Section 1 of this Warrant; provided, however, that the Corporation
may change its principal office upon notice to the Holder. This
Warrant is not exercisable with respect to a fraction of a share of
Common Stock. In lieu of issuing a fraction of a share remaining
after exercise of this Warrant as to all full shares covered by
this Warrant, the Corporation shall either at its option (a) pay
cash for the fractional share in an amount equal to the fraction so
issuable multiplied by the then fair market price for the shares of
Common Stock; or (b) issue scrip for the fraction in registered or
bearer form, which shall entitle the Holder to receive a
certificate for a full share of Common Stock on surrender of scrip
aggregating a full share.

 

4. 
Protection
Against Dilution. If the Corporation, with respect to the
Common Stock, (1) pays a dividend or makes a distribution on
shares of common stock that is paid in shares of common stock or in
securities convertible into or exchangeable for Common Stock (in
which latter event the number of shares of common stock initially
issuable upon the conversion or exchange of such securities shall
be deemed to have been distributed), (2) subdivides outstanding
shares of Common Stock, (3) combines outstanding shares of
Common Stock into a smaller number of shares, or (4) issues by
reclassification of common stock any shares of capital stock of the
Corporation, the Exercise Price in effect immediately prior thereto
shall be adjusted so that each Holder thereafter shall be entitled
to receive the number and kind of shares of Common Stock or other
capital stock of the Corporation that it would have owned or been
entitled to receive in respect of this Warrant immediately after
the happening of any of the events described above had this Warrant
been converted immediately prior to the happening of that event. An
adjustment made in accordance with this Section shall become
effective immediately after the record date, in the case of a
dividend, and shall become effective immediately after the
effective date, in the case of a subdivision, combination, or
reclassification. If, as a result of an adjustment made in
accordance with this Section 4, the Holder becomes entitled to
receive shares of two or more classes of capital stock or shares of
common stock and other capital stock of the Corporation, the board
of directors (whose determination shall be conclusive) shall
determine the allocation of the adjusted Exercise Rate between or
among shares of such classes of capital stock or shares of Common
Stock and other capital stock.

 

 

-1-

 

 

5.        
Adjustment for
Reorganization, Consolidation, Merger, Etc. In the event of
any consolidation or merger to which the Corporation is a party
other than a consolidation or merger in which the Corporation is
the continuing corporation, or the sale or conveyance to another
corporation of the property of the Corporation as an entirety or
substantially as an entirety or any statutory exchange of
securities with another corporation (including any exchange
effected in connection with a merger of a third corporation into
the Corporation) (each such transaction referred to herein as
“Reorganization”), the
Corporation shall give notice to the holder of this Warrant at
least five (5) days prior to the closing of such transaction (such
notice to be deemed given if publicly reported in a press release
or filing with the Securities and Exchange Commission) and the
Holder shall thereupon be entitled to receive and provision shall
be made therefor in any
agreement relating to a Reorganization, the kind and number of
securities or property (including cash) of the Corporation
resulting from such consolidation or surviving such merger or to
which such properties and assets shall have been sold or otherwise
transferred or with whom securities have been exchanged, which the
Holder would have owned or been entitled to receive as a result of
such Reorganization had this Warrant been exercised immediately
prior to such Reorganization (and assuming the Holder failed to
make an election, if any was available, as to the kind or amount of
securities, property or cash receivable by reason of such
Reorganization; provided that if the kind or amount of securities,
property or cash receivable upon such Reorganization is not the
same for each share of common stock in respect of which such rights
of election shall not have been exercised (“non-electing
share”) then for the purpose of this Section the kind and
amount of securities, property or cash receivable upon such
Reorganization for each non-electing share shall be deemed to be
the kind and amount so receivable per share by a plurality of the
non-electing shares). In any case, appropriate adjustment shall be
made in the application of the provisions herein set forth with
respect to the rights and interests thereafter of the Holder, to
the end that the provisions set forth herein (including the
specified changes and other adjustments to the conversion rate)
shall thereafter be applicable, as nearly as reasonably may be, in
relation to any shares, other securities or property thereafter
receivable upon exercise of this Warrant. The provisions of this
Section similarly apply to successive
Reorganizations.

 

6.         
Notice of
Adjustment. Upon the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under
this Warrant, the Corporation shall, within thirty (30) days, give
written notice to the Holder stating the adjusted Exercise Price
and the adjusted number and kind of securities or other property
purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts
upon which the calculation is based.

 

7.         
Dissolution,
Liquidation. In case of the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other
than in connection with reorganization, consolidation, merger, or
other transaction covered by Section 5 above) is at any time
proposed, the Corporation shall give at least twenty (20) days
prior written notice to the Holder. Such notice shall contain: (a)
the date on which the transaction is to take place; (b) the record
date (which shall be at least twenty (20) days after the giving of
the notice) as of which holders of Common Stock will be entitled to
receive distributions as a result of the transaction; (c) a brief
description of the transaction; (d) a brief description of the
distributions to be made to holders of Common Stock as a result of
the transaction; and (e) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually
occurs, this Warrant and all rights under this Warrant shall
terminate.

 

 

 

-2-

 

 

8.           
Rights of Holder.
This Warrant does not entitle the Holder to any voting rights or,
except for the foregoing notice provisions, any other rights as a
shareholder of the Corporation. No dividends are payable or will
accrue on this Warrant or the shares of Common Stock purchasable
under this Warrant until, and except to the extent that, this
Warrant is exercised. Upon the surrender of this Warrant and
payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon
such exercise shall be treated for all purposes as the record
holder of such shares as of the close of business on the date of
the surrender of this Warrant for exercise as provided above. Upon
the exercise of this Warrant, the Holder shall have all of the
rights of a shareholder in the Corporation.

 

9.           
Exchange for Other
Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of
like tenor and date representing in the aggregate the right to
purchase the balance of the number of shares purchasable under this
Warrant in denominations and subject to restrictions on transfer
contained herein, in the names designated by the Holder at the time
of surrender.

 

10.         
Substitution. Upon
receipt by the Corporation of evidence satisfactory (in the
exercise of reasonable discretion) to it of the ownership of and
the loss, theft or destruction or mutilation of this Warrant, and
(in the case or loss, theft or destruction) of indemnity
satisfactory (in the exercise of reasonable discretion) to it, and
(in the case of mutilation) upon the surrender and cancellation
thereof, the Corporation will issue and deliver, in lieu thereof, a
new Warrant of like tenor.

 

11.          
Restrictions on
Transfer. Neither this Warrant nor the shares of Common
Stock issuable upon exercise of this Warrant have been registered
under the Securities Act of 1933, as amended, or any other
securities laws (the “Acts”). Neither this Warrant nor
the shares of Common Stock purchasable hereunder may be sold,
transferred, pledged or hypothecated in the absence of (a) an
effective registration statement for this Warrant or the shares of
Common Stock purchasable hereunder, as applicable, under the Acts,
or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. If
the Holder seeks an opinion from Holder’s counsel as to
transfer without registration, the Corporation shall provide such
factual information to Holder’s counsel as Holder’s
counsel reasonably requests for the purpose of rendering such
opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions
on transfer contained in this paragraph unless, in the opinion of
counsel reasonably acceptable to the Corporation, the shares need
no longer to be subject to the transfer restrictions.

 

12.           Transfer.
Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in
person or by attorney, on surrender of this Warrant, properly
endorsed.

 

13.           Recognition
of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as
the person exclusively entitled to receive notices and otherwise to
exercise rights under this Warrant. All notices required or
permitted to be given to the Holder shall be in writing and shall
be given by first class mail, postage prepaid, addressed to the
Holder at the address of the Holder appearing in the records of the
Corporation.

 

 

-3-

 

 

14.           Payment
of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes, that may
be imposed with respect to the issuance of shares of Common Stock
pursuant to the exercise of this Warrant.

 

15.           Headings.
The headings in this Warrant are for purposes of convenience in
reference only, shall not be deemed to constitute a part of this
Warrant and shall not affect the meaning or construction of any of
the provisions of this Warrant.

 

16.           Miscellaneous.
This Warrant may not be changed, waived, discharged or terminated
except by an instrument in writing signed by the Corporation and
the Holder. This Warrant shall inure to the benefit of and shall be
binding upon the successors and assigns of the Corporation. Under
no circumstances may this Warrant be assigned by the
Holder.

 

17.           Governing
Law. This Warrant shall be governed by and construed in
accordance with the laws of the State of Delaware without giving
effect to its principles governing conflicts of law.

 

 

YOUNGEVITY
INTERNATIONAL, INC.

 

By:
___________________________________

Name:

Title:

 

 

-4-

 

 

YOUNGEVITY INTERNATIONAL, INC.

Form of Transfer

 

 

(To be
executed by the Holder to transfer the Warrant)

 

 

For
value received the undersigned registered holder of the attached
Warrant hereby sells, assigns, and transfers the Warrant to the
assignee(s) named below:

 

	
Names
of Assignee

	
Address

	
Taxpayer ID No.

	
 Number of shares subject to
transferred Warrant

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

 

 

The
undersigned registered holder further irrevocably appoints
____________________ _______________________________ attorney (with
full power of substitution) to transfer this Warrant as aforesaid
on the books of the Corporation.

 

 

 

 

 

 

Date:______________________________                                                                                                 

___________________________________

 

                                
Signature   
       

 

 

 

 

-5-

 

 

YOUNGEVITY INTERNATIONAL, INC.

Exercise Form

 

(To be
executed by the Holder to purchase

Common
Stock pursuant to the Warrant)

 

 

The
undersigned holder of the attached Warrant hereby irrevocably
elects to exercise purchase rights represented by such Warrant for,
and to purchase, ___________ shares of Common Stock of Youngevity
International, Inc., a Delaware corporation. The undersigned
tenders cash payment for those shares.

 

The
undersigned requests that (1) a certificate for the shares be
issued in the name of the undersigned and (2) if the number of
shares with respect to which the undersigned holder has exercised
purchase rights is not all of the shares purchasable under this
Warrant, that a new Warrant of like tenor for the balance of the
remaining shares purchasable under this Warrant be
issued.

 

 

 

 

Date:______________________________                                                                                                 

___________________________________

 

                                 
Signature   
       

 

 

 

 

 

 

-6-Exhibit 10.1

 

Exhibit
10.1

 

July
31, 2018

 

CONFIDENTIAL

 

Dave
Briskie

Youngevity
International, Inc.

2400
Boswell Road

Chula
Vista, CA 91914

 

 

Dear
Mr. Briskie:

 

This letter (the "Agreement") confirms Corinthian
Partners, LLC ("CP") engagement as an exclusive placement agent for
Youngevity International, Inc. (“Youngevity”), a
Delaware corporation, in connection with the proposed Capital Raise
(the ''Offering") of
up to Three Million
dollars ($3,000,000), or more as agreed, of the Company's
securities (the "Securities") as outlined in the Convertible
Preferred Stock Term Sheet, Share Purchase Agreement, and
associated documents dated on or about August 1, 2018 (the "Term
Sheet"). It is anticipated that the Securities will be sold only to
"accredited investors" (the "Investors"), as such term is defined
in Rule 501(a) of Regulation D, promulgated under the United States
Securities Act of 1933, as amended, pursuant to an exemption from
registration under Rule 506 of Regulation D.

 

Subject
to the terms and conditions of this Agreement, the Company hereby
appoints CP to act on a best efforts basis as its exclusive
placement agent to privately place the Securities in an amount and
on terms and conditions satisfactory to the Company. CP hereby
accepts such engagement and agrees to use its best efforts to
privately place the Securities with potential Investors. The
Company shall promptly refer to CP all offers, inquiries and
proposals relating to any placement of the Securities made at any
time during the Term (as defined below).

 

1. Services to
be Rendered. In connection with
the Offering, as requested, CP will assist the Company in
structuring the proposed Offering, identifying, contacting and
evaluating potential purchasers, preparing executive summaries or
business plans, facilitating potential
purchasers due
diligence investigations, analyzing and advising on the financial
implications of offers, preparing and making presentations to the
Company's Board of Directors, formulating negotiation strategies
and conducting negotiations, as appropriate, and in such other
matters as may be agreed upon from time to time by CP and the
Company (the ''Services").

 

In connection with this Agreement, the Company
agrees to keep CP up to date and apprised of all material business,
market and current legal practices and developments related to the
Company and its operations and management. CP shall devote such
time and effort, as it deems commercially reasonable under the
circumstances in rendering the Services. CP cannot guarantee
results on behalf of the Company, but shall use its best efforts to
pursue all avenues that it deems reasonable through its network of
contacts. CP will post the Offering on its web portal,
https://ignitionfunding.com/.

 

2. Compensation.
For CP's services hereunder, the
Company agrees to pay CP the fees outlined below upon closing of a
sale of any of the Securities (in each instance, a
"Closing"):

 

(a) a
placement fee equal to five percent (5.0%)
of the gross purchase price paid for the Securities,
payable in full, in cash, at a Closing for the sale of any of the
Securities, and a non-accountable expense allowance equal to two
percent (2.00%) of the gross proceeds of the
Offering.

 

(b) the
Company shall issue to CP, or its permitted assigns, warrants (the
"PA Warrants") of the Company equal to ten percent (10%) of the
warrants issued to investors pursuant to the Offering, if and when
the warrants are issued to the investors. The PA Warrants shall be
transferable by CP to its permitted assigns, representatives and
agents.

 

(c) Notwithstanding
anything to the contrary contained herein no placement fee or PA
Warrants shall be paid or issued to CP with respect to any
Securities sold to the Company’s officers, directors,
shareholders who not are already existing clients of CP, or any of
the individuals or entities set forth on Exhibit B hereto. An
Escrow Account (the "Escrow Account") with a third-party agent
approved by the parties hereto will be used for each closing during
the Term. All consideration due CP shall be paid to CP directly
from such escrow. Any fee charged by the escrow agent in the
performance of its duties as escrow agent shall be borne by the
Company.

 

In
the event there are multiple partial closings prior to the final
closing of the Transaction, the Company shall pay CP a pro-rata
portion of the cash portion of the Transaction Fee and shall issue
to CP, or its designees, a pro-rata portion of the PA Warrants as
soon as is practicable when earned.

 

 

-1-

 

 

 

3. RESERVED

 

4. Information.
The Company will furnish CP such
information with respect to the Company and access to such Company
personnel and representatives, including the Company's auditors and
counsel, as CP may request in order to permit CP to advise the
Company and to assist the Company in preparing offering materials
for use in connection with the Offering (including, but not limited
to: a business plan; executive summary; three (3) year historical
income statement, statement of cash flows, and balance. sheet;; use
of proceeds statement; investor presentation; valuation analysis)
(collectively, the "Offering Materials"). The Company will be
solely responsible for the contents of the Offering Materials and
other information provided to investors in connection with the
Offering. The Company represents and warrants to CP that the
Offering Materials will not contain any untrue statement of a
material fact or omit to state a material fact necessary to make
the statements therein, in light of the circumstances under which
they were made, not misleading. The Company agrees to advise CP
promptly upon the Company becoming aware of the occurrence of any
event or change in circumstance that results or might reasonably be
expected to result in the Offering Materials containing any untrue
statement of a material fact or omitting to state a material fact
necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. The
Company authorizes CP to provide the Offering Materials to
investors in connection with the Offering. The Company and CP shall
have the right to approve every form of letter, circular, notice,
memorandum or other written communication from the Company or any
person acting on its behalf in connection with the
Offering.

 

5. Termination
and Survival. The term of our engagement hereunder shall be for
a period commencing on the date hereof and expiring on the earlier
of the final closing of a Transaction, unless sooner terminated or
extended pursuant to the following sentences (the "Term"). This
Agreement may be terminated prior to expiration of the Term, by CP
or Youngevity for any reason at any time upon fifteen (15) days
prior written notice. Notwithstanding the foregoing, it is
understood that the provisions of paragraphs 2 (to the extent fees
are payable prior to termination}, Paragraph 2(c) (to the extent
fees are payable after termination), 3 (to the extent expenses have
been incurred prior to termination), and sections 6 through 18
of this Agreement shall remain operative and in full
force and effect regardless of any termination or expiration of
this Agreement. In the event of termination, CP shall be
immediately paid in full on all items of compensation and expenses
payable to CP pursuant hereto, as of the date of
termination.

 

6. [RESERVED]

 

7. Confidentiality
of Advice. Except as otherwise provided in this paragraph,
any written or other advice rendered by CP pursuant to its
engagement hereunder are solely for the use and benefit of the
Company's executive management team and Board of Directors and
shall not be publicly disclosed in whole or in part, in any manner
or summarized, excerpted from or otherwise publicly referred to or
made available to third parties, other than representatives and
agents of the Company's executive management team and Board of
Directors who also shall not disclose such information, in each
case, without CPs prior approval,. unless in the opinion of counsel
..and after consultation with CP, such disclosure is required by
law. In addition, other than in connection with discussions with
potential Investors with respect to potential sales of Securities
or as required by law, CP may not be otherwise publicly referred to
without its prior written consent. The Company acknowledges that CP
and its affiliates are in the business of providing financial
services and consulting advice to others. Nothing herein contained
shall be construed to limit or restrict CP in conducting such
business with respect to others, or in rendering such advice to
others, except as such advice may relate to matters relating to the
Company's business and properties and that might compromise
confidential information delivered by the Company to CP. CP agrees
to maintain the confidentiality of all non-public information
provided to it by the Company and not to use such information for
any purpose other than in accordance with disclosures approved by
the Company.

 

8. Obligations
Limited. CP shall have no obligation to make any
independent appraisals of assets or liabilities or any independent
verification of the accuracy or completeness of any information
provided it in the course of this engagement and shall have no
liability in regard thereto.

 

9. Third Party
Beneficiaries. This Agreement is made solely for the benefit of
the Board of Directors of the Company, CP and other Indemnified
Persons (as defined herein), and their respective successors,
assigns, heirs and personal representatives, and no other person
shall acquire or have any right under or by virtue of this
Agreement.

 

 

 

-2-

 

 

 

10. Representations
and Warranties. The Company
represents and warrants that this Agreement has been duly
authorized, executed and delivered by the Company and constitutes a
legal valid and binding obligation of the
Company.

 

 CP
represents that it is a FINRA licensed broker-dealer in good
standing with the SEC and each state securities authority in which
it offers or sells securities and has an anti-money laundering
program in place reasonably designed to comply with Section 352 of
the USA Patriot Act, NASO Rule 3011, and NYSE Rule 445. CP's
anti-money laundering program includes: (i) Anti-Money
Laundering/"Know Your Customer" policies and procedures (ii) the
designation of an Anti-Money Laundering Compliance Officer; (iii}
recording-keeping and reporting practices in accordance with
applicable law; (iv) reporting of suspicious. activity to
government authorities in accordance with applicable law; (v)
anti-money laundering training; and (vi) independent testing for
compliance. CP will provide such periodic reports or certifications
to the Company regarding this program as the Company may reasonably
request. CP’s web
portal, https://ignitionfunding.com/,
complies in all respects with applicable law. Insofar as the
offering shall be made pursuant to Rule 506(c), CP shall have
verified that each investor in the Offering is an accredited
investor under Rule 506 (c) of the Securities Act of 1933, and
shall have taken the following action to satisfy the requirements
of Rule 506(c): (i) reviewed an IRS form provided by the investor
that reports such investor’s income for the two most recent
years as meeting an accredited investor status and received a
written representation from the investor that it reasonably expects
to reach the income level required to qualify as an accredited
investor in the current year; (ii) reviewed one or more documents
dated within the past three months to confirm assets as well as a
report from a national consumer reporting agency to confirm
liabilities of the investor and received a written representation
from the investor that it has disclosed all liabilities necessary
to make a net worth determination; and (iii) obtained a
written representation from a regsitered broker-dealer, registered
investment advisor, licensed attorney or certified public
accountant that has been verified to be an independent third party
that has determined that the purchaser is an accredited
investor.

 

12.
    Indemnification. In
connection with and as part of the engagement contemplated herein,
each party agrees to indemnify, defend and hold the other party
harmless in accordance with the indemnification rider attached
hereto as Exhibit
A.

 

13. Non-Circumvention.
The Company agrees not to circumvent,
avoid, bypass, or obviate directly or indirectly, the intent of
this Agreement, including that the Company shall not permit its
subsidiaries and its other affiliated entities to sell securities
with the effect of avoiding payment of fees under this Agreement.
The Company agrees that during the term of this Agreement and for a
period of six (6) months after the termination of this Agreement
not to accept any financing upon the terms set forth in the Term
Sheet from any third party whom CP first introduces to the
Company via
an in person, a telephonic meeting or through CP’s
web portal, https://ignitionfunding.com/,
or who is a current client of CP and otherwise becomes an investor
in the Company by reason of CP’s investment advice (which
would exclude by definition, and require more than, an “email
blast” by CP to its clients), without the consent of CP,
unless for each business opportunity accepted by the Company from a
third party introduced by CP or otherwise, the Company remits a
term sheet providing for compensation to CP in accordance herewith,
or which otherwise provides for compensation structure agreeable to CP, in its
sole discretion.

 

14. Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be
governed by the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or
rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions
other than the State of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal
courts sitting in New York, New York, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof to
such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT TO A JURY TRIAL, AND AGREES NOTTO
REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY.

 

15. Legal Fees
and Costs. If a legal action is initiated by any party to
this Agreement against another; arising out of or relating to the
alleged performance or non performance of any right or obligation
established hereunder, or any dispute concerning the same, any and
all fees, costs and expenses reasonably incurred by each successful
party or his, her or its legal counsel in investigating, preparing
for, prosecuting, defending against, or providing evidence and
producing documents or taking any other action in respect of such
action shall be the joint and several obligation of the
unsuccessful party(ies) and shall be paid or reimbursed by the
unsuccessful party(ies).

 

16. Severability. If
one or more provisions of this Agreement are held to be
unenforceable under applicable law, the parties agree to
renegotiate such provision in good faith. In the event that the
parties cannot reach a mutually agreeable and enforceable
replacement for such provision, then (a) such provision shall be
excluded from this Agreement, (b) the balance of the Agreement
shall be interpreted as if such provision were so excluded and (c)
the balance of the Agreement shall be enforceable in accordance
with its terms.

 

 

-3-

 

 

 

17. Future
Advertisements. The Company
agrees that CP has the right to place advertisements describing its
services to the Company under this Agreement in its own marketing
materials as well as financial and other newspapers and journals at
its own expense following the final closing of the
Offering.

 

18. Miscellaneous. (a)
This Agreement and the documents referred to herein constitute the
entire agreement between the parties hereto pertaining to the
subject matter hereof, and any and all other written or oral
agreements existing between the parties hereto are expressly
cancelled; (b) Only an instrument in writing executed by the
parties hereto may amend this Agreement; (c) The failure of any
party to insist upon strict performance of any of the provisions of
this Agreement shall not be construed as a waiver
of any subsequent default of the same or similar
nature, or any other nature; (d) This Agreement may be executed in
two (2) or more counterparts, each of which shall be deemed an
original and all of which together shall: constitute one (1)
instrument; (e) This Agreement shall be binding on and inure to the
benefit of the parties hereto and their respective successors and
permitted assigns. The rights and obligations of the parties under
this Agreement may not be assigned or delegated without the prior
written consent of both parties, and any purported assignment
without such written consent shall be null and
void.

 

 

[The
remainder of this page is intentionally left blank.]

 

 

 

 

-4-

 

 

If the
foregoing correctly sets forth the understanding between CP and the
Company, please so indicate in the space provided below for that
purpose within five business (5) days of the date hereof or this
Agreement shall be withdrawn and become null and void. The
undersigned parties hereto have caused this Agreement to be duly
executed by their authorized representatives, pursuant to corporate
board approval and intend to be legally bound.

 

 

Corinthian Partners, LLC

 

 

By:                                           

Date:                                                      

Name:                                                       

Principal

 

 

Youngevity Corporation

 

 

By:                                           

Date:                                                    

Dave
Briskie

President
and CFO

 

 

 

-5-

 

EXHIBIT
A

 

 INDEMNIFICATION AND
CONTRIBUTION

 

 

For
purposes of this Exhibit
A unless the context otherwise requires, "CP" shall include
CP, any affiliated entity, and each of their respective officers,
directors, employees, partners and controlling persons within the
meaning of the federal securities laws and the successors, assigns,
heirs and personal representatives of the foregoing persons and the
“Company shall include the Company, any affiliated entity,
and each of their respective officers, directors, employees,
partners and controlling persons within the meaning of the federal
securities laws and the successors, assigns, heirs and personal
representatives of the foregoing persons . Any capitalized terms
used and not otherwise defined in this Exhibit A shall have the
meanings ascribed to such capitalized terms in the agreement (the
“Agreement”) to which this Exhibit A is
attached.

 

The
Company shall indemnify, defend and hold CP harmless against any
losses, claims, damages, liabilities, costs and expenses
(including, without limitation, any legal or other expenses
incurred in connection with investigating, preparing to defend or
defending against any action, claim, suit or proceeding, whether
commenced or threatened (collectively, “Claims”) and
whether or not CP is a party thereto, or in appearing or preparing
for appearance as a witness, based upon, relating to or arising out
of or in connection with advice or services rendered or to be
rendered pursuant to the Agreement, the transaction contemplated
thereby or CP's actions or inactions in connection with any such
advice, services or transaction (including, but not limited to, any
liability arising out of (i) any misstatement or alleged
misstatement of a material fact in any offering materials and (ii)
any omission or alleged omission from any offering materials,
including, without limitation of a ,material fact necessary to make
the statements therein, in light of the circumstances under which
they were made, not misleading}, except to the extent that any such
loss, claim, damage, liability, cost or expense results solely from
the gross negligence or bad
faith of CP in performing the services which are the subject of the
Agreement. If for any reason the foregoing indemnification is
unavailable to CP or insufficient to hold it harmless, then the
Company shall contribute to the amount paid or payable by CP as a
result of suct1 loss, claim, damage or liability in such proportion
as is appropriate to reflect the relative benefits received by the
Company and its stockholders on the one hand and CP on the other
hand, or, if such allocation is not permitted by applicable law,
not only such relative benefits but also the relative fault of the
Company and CP, as well as any relevant equitable considerations;
provided, however, that, to the extent permitted by applicable law,
CP shall not be responsible for amounts which in the aggregate are
in excess of the amount of all fees actually received from the
Company in connection with the engagement. No person guilty of
fraudulent misrepresentation (as such term has been interpreted
under Section 11(f) of the Securities Act of 1933) shall be
entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. Relative benefits to CP, on the one
hand, and the Company and its stockholders, on the other hand, with
respect to the engagement shall be deemed to be in the same
proportion as (i) the total value paid or proposed to be paid or
received or proposed to be received by the Company or its
stockholders, as the case may be, pursuant to the potential
transaction., whether or not consummated, contemplated by the
engagement bears to (ii) all fees paid to CP by the Company in
connection with the engagement. CP shall not have any liability to
the Company in connection with the engagement, except to the extent
of its gross negligence or willful misconduct.

 

CP
shall indemnify, defend and hold the Company harmless against any
Claims and whether or not the Company is a party thereto, or in
appearing or preparing for appearance as a witness, based upon,
relating to or arising out of or in connection with a breach of the
terms of the Agreement by CP or CP’s gross negligence or
willful misconduct. If for any reason the foregoing indemnification
is unavailable to the Company or insufficient to hold it harmless,
then CP shall contribute to the amount paid or payable by the
Company as a result of such loss, claim, damage or liability in
such proportion as is appropriate to reflect the relative benefits
received by the Company and its stockholders on the one hand and CP
on the other hand, or, if such allocation is not permitted by
applicable law, not only such relative benefits but also the
relative fault of the Company and CP, as well as any relevant
equitable considerations; provided, however, that, to the extent
permitted by applicable law, the Company shall not be responsible
for amounts which in the aggregate are in excess of the amount of
all fees actually paid by the Company in connection with the
engagement. No person guilty of fraudulent misrepresentation (as
such term has been interpreted under Section 11(f) of the
Securities Act of 1933) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation.
Relative benefits to CP, on the one hand, and the Company and its
stockholders, on the other hand, with respect to the engagement
shall be deemed to be in the same proportion as (i) the total value
paid or proposed to be paid or received or proposed to be received
by the Company or its stockholders, as the case may be, pursuant to
the potential transaction., whether or not consummated,
contemplated by the engagement bears to (ii) all fees paid to CP by
the Company in connection with the engagement. CP shall not have
any liability to the Company in connection with the engagement,
except to the extent of its gross negligence or willful
misconduct.

 

The
indemnifying party also agrees to promptly upon demand reimburse
the indemnified party for its reasonable legal and other expenses
reasonably incurred by it for one legal counsel in connection with
investigating, preparing to defend, or defending any lawsuits,
investigations, claims or other proceedings in connection with any
matter referred to in or otherwise contemplated by the Agreement;
provided, however, that in the event a final judicial determination
is made to the effect that the indemnified party is not entitled to
indemnification hereunder, the indemnified party will remit to the
indemnifying party any amounts that have been so
reimbursed.

 

No
party shall not be liable for any settlement of any action, claim,
suit or proceeding (or for any related losses, damages,
liabilities, costs or expenses) if such settlement is effectuated
without its written consent, which shall not be unreasonably
withheld. Each party further agrees that it will not settle or
compromise or consent to the entry of any judgment in any pending
or threatened action, claim, suit or proceeding in respect of which
Indemnification or contribution may be sought hereunder (whether or
not it is a party therein) unless the other party has obtained an
unconditional release of such party, from all liability arising
therefrom. The reimbursement, indemnity and contribution
obligations of the parties set forth in this Agreement shall be in
addition to a:ny liability which such party may otherwise have to
the other party.

 

Any
Indemnified Persons that are not signatories to this Agreement
shall be deemed to be third party beneficiaries of this
Agreement.

 

 

 

-6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]